The Seroepidemiology of Haemophilus influenzae Type B Prior to Introduction of an Immunization Programme in Kathmandu, Nepal

• Andrew S. J. Marshall ,

  * E-mail: a.marshall@doctors.org.uk

  Affiliation Oxford Vaccine Group, Oxford University, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Charlotte I. S. Barker,

  Affiliation Oxford Vaccine Group, Oxford University, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Anoop S. Pulickal,

  Affiliation Oxford Vaccine Group, Oxford University, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Elizabeth Kibwana,

  Affiliation Oxford Vaccine Group, Oxford University, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Samir C. Gautam,

  Affiliation Patan Hospital, Kathmandu, Nepal

  ⨯
• Elizabeth A. Clutterbuck,

  Affiliation Oxford Vaccine Group, Oxford University, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Stephen M. Thorson,

  Affiliation Patan Hospital, Kathmandu, Nepal

  ⨯
• Shrijana Shrestha,

  Affiliation Patan Hospital, Kathmandu, Nepal

  ⨯
• Neelam Adhikari,

  Affiliation Patan Hospital, Kathmandu, Nepal

  ⨯
• Andrew J. Pollard,

  Affiliation Oxford Vaccine Group, Oxford University, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯
• Dominic F. Kelly

  Affiliation Oxford Vaccine Group, Oxford University, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

  ⨯